{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:36:40Z","timestamp":1783953400761,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07831-w","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:17:34Z","timestamp":1771060654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["TIPE2 knockdown enhances the anti-tumor efficacy of NKG2D CAR-T cells against pancreatic cancer via activating NF-\u03bab signaling pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Muhammad Asad","family":"Farooq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingtan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqra","family":"Ajmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4999-4168","authenticated-orcid":false,"given":"Wenzheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"issue":"2","key":"7831_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12033-024-01090-0","volume":"67","author":"R Thirumalaisamy","year":"2025","unstructured":"Thirumalaisamy R, et al. FDA-Approved Chimeric antigen receptor (CAR)-T cell therapy for different cancers-A Recent perspective. Mol Biotechnol. 2025;67(2):469\u201383.","journal-title":"Mol Biotechnol"},{"issue":"1","key":"7831_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","volume":"21","author":"SM Albelda","year":"2024","unstructured":"Albelda SM. CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. Nat Rev Clin Oncol. 2024;21(1):47\u201366.","journal-title":"Nat Rev Clin Oncol"},{"key":"7831_CR3","doi-asserted-by":"crossref","unstructured":"Levine BL, et al. Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. nature medicine. 2024;30(2):338\u201341.","DOI":"10.1038\/s41591-023-02767-w"},{"key":"7831_CR4","doi-asserted-by":"publisher","first-page":"115740","DOI":"10.1016\/j.biopha.2023.115740","volume":"168","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, et al. Co-expression of IL-4\/IL-15-based inverted cytokine receptor in CAR-T cells overcomes IL-4 signaling in immunosuppressive pancreatic tumor microenvironment. Biomed Pharmacother. 2023;168:115740.","journal-title":"Biomed Pharmacother"},{"key":"7831_CR5","doi-asserted-by":"publisher","first-page":"1368732","DOI":"10.3389\/fonc.2024.1368732","volume":"14","author":"Y Lv","year":"2024","unstructured":"Lv Y, et al. Prospects and challenges of CAR-T cell therapy combined with ICIs. Front Oncol. 2024;14:1368732.","journal-title":"Front Oncol"},{"issue":"1","key":"7831_CR6","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1038\/s41467-024-47799-z","volume":"15","author":"I Andreu-Saumell","year":"2024","unstructured":"Andreu-Saumell I, et al. CAR affinity modulates the sensitivity of CAR-T cells to PD-1\/PD-L1-mediated inhibition. Nat Commun. 2024;15(1):3552.","journal-title":"Nat Commun"},{"issue":"10","key":"7831_CR7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41423-024-01207-0","volume":"21","author":"L Peng","year":"2024","unstructured":"Peng L, et al. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors. Cellular Mol Immunol. 2024;21(10):1089\u2013108.","journal-title":"Cellular Mol Immunol"},{"issue":"5","key":"7831_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell.2019.09.006","volume":"36","author":"R Grosser","year":"2019","unstructured":"Grosser R, et al. Combination immunotherapy with CAR T cells and checkpoint blockade for the treatment of solid tumors. Cancer Cell. 2019;36(5):471\u201382.","journal-title":"Cancer Cell"},{"key":"7831_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.08.028","volume-title":"Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer","author":"I Ajmal","year":"2024","unstructured":"Ajmal I, et al. Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer. Molecular Therapy; 2024."},{"key":"7831_CR10","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.canlet.2018.06.017","volume":"432","author":"G Padmavathi","year":"2018","unstructured":"Padmavathi G, et al. Novel tumor necrosis factor-\u03b1 induced protein eight (TNFAIP8\/TIPE) family: functions and downstream targets involved in cancer progression. Cancer Lett. 2018;432:260\u201371.","journal-title":"Cancer Lett"},{"key":"7831_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-025-02288-3","volume-title":"TIPE2 alleviates sepsis-induced Lung Injury by inhibiting PANoptosis in murine alveolar macrophages","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. TIPE2 alleviates sepsis-induced Lung Injury by inhibiting PANoptosis in murine alveolar macrophages. Inflammation; 2025."},{"issue":"1","key":"7831_CR12","doi-asserted-by":"publisher","first-page":"8819584","DOI":"10.1155\/2023\/8819584","volume":"2023","author":"H Hu","year":"2023","unstructured":"Hu H, et al. Clinical significance of decreased TIPE2 expression in peripheral blood mononuclear cells of patients with psoriasis vulgaris. Dermatologic Ther. 2023;2023(1):8819584.","journal-title":"Dermatologic Ther"},{"issue":"3","key":"7831_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cell.2008.04.017","volume":"133","author":"EC Freundt","year":"2008","unstructured":"Freundt EC, Bidere N, Lenardo MJ. A different TIPE of immune homeostasis. Cell. 2008;133(3):401\u201302.","journal-title":"Cell"},{"issue":"1","key":"7831_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.molimm.2014.11.019","volume":"64","author":"W Zhang","year":"2015","unstructured":"Zhang W, et al. TIPE2 protein negatively regulates HBV-specific CD8+ T lymphocyte functions in humans. Mol Immunol. 2015;64(1):204\u201309.","journal-title":"Mol Immunol"},{"issue":"3","key":"7831_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cell.2008.03.026","volume":"133","author":"H Sun","year":"2008","unstructured":"Sun H, et al. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell. 2008;133(3):415\u201326.","journal-title":"Cell"},{"issue":"1","key":"7831_CR16","doi-asserted-by":"publisher","first-page":"27954","DOI":"10.1038\/s41598-025-10449-5","volume":"15","author":"H Xia","year":"2025","unstructured":"Xia H, et al. TIPE2 combined with immune cell infiltration predicts prognosis in colorectal cancer. Sci Rep. 2025;15(1):27954.","journal-title":"Sci Rep"},{"key":"7831_CR17","doi-asserted-by":"crossref","unstructured":"Bi J, et al. TIPE2 deletion improves the therapeutic potential of adoptively transferred NK cells. J Immunother Cancer. 2023;11(2).","DOI":"10.1136\/jitc-2022-006002"},{"key":"7831_CR18","doi-asserted-by":"crossref","unstructured":"Bi J, et al. TIPE2 is a checkpoint of natural killer cell maturation and antitumor immunity. Sci Adv. 2021;7(38):eabi 6515.","DOI":"10.1126\/sciadv.abi6515"},{"key":"7831_CR19","doi-asserted-by":"crossref","unstructured":"Bi J, et al. Checkpoint TIPE2 limits the helper functions of NK cells in supporting antitumor CD8+ T cells. Adv Sci. 2023;2207499.","DOI":"10.1002\/advs.202207499"},{"key":"7831_CR20","doi-asserted-by":"publisher","first-page":"1369406","DOI":"10.3389\/fimmu.2024.1369406","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. shRNA-mediated gene silencing of HDAC11 empowers CAR-T cells against prostate cancer. Front Immunol. 2024;15:1369406.","journal-title":"Front Immunol"},{"key":"7831_CR21","doi-asserted-by":"crossref","unstructured":"Su Q, et al. Modulating cholesterol metabolism via ACAT1 knockdown enhances anti-B-Cell lymphoma activities of CD19-specific Chimeric antigen receptor T cells by Improving the cell activation and proliferation. Cells. 2024;13(6).","DOI":"10.3390\/cells13060555"},{"issue":"9","key":"7831_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41389-021-00353-8","volume":"10","author":"Y Gao","year":"2021","unstructured":"Gao Y, et al. Suppression of 4.1 R enhances the potency of NKG2D-CAR T cells against pancreatic carcinoma via activating ERK signaling pathway. Oncogenesis. 2021;10(9):62.","journal-title":"Oncogenesis"},{"key":"7831_CR23","first-page":"36","volume-title":"Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cells","author":"L Lin","year":"2014","unstructured":"Lin L, et al. Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cells. 15. BMC Immunol; 2014. 36."},{"issue":"7","key":"7831_CR24","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.4049\/jimmunol.1201556","volume":"190","author":"LM McLane","year":"2013","unstructured":"McLane LM, et al. Differential localization of T-bet and Eomes in CD8 T cell memory populations. The J Immunol. 2013;190(7):3207\u201315.","journal-title":"The J Immunol"},{"key":"7831_CR25","doi-asserted-by":"crossref","unstructured":"Gumber D, Wang LD. Improving CAR-T immunotherapy: overcoming the challenges of T cell exhaustion. EBioMedicine. 2022;77.","DOI":"10.1016\/j.ebiom.2022.103941"},{"issue":"4","key":"7831_CR26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nbt.4086","volume":"36","author":"K Adachi","year":"2018","unstructured":"Adachi K, et al. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor. Nat Biotechnol. 2018;36(4):346\u201351.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"7831_CR27","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1158\/0008-5472.CAN-04-2006","volume":"65","author":"J Charo","year":"2005","unstructured":"Charo J, et al. Bcl-2 overexpression enhances tumor-specific T-cell survival. Cancer Res. 2005;65(5):2001\u201308.","journal-title":"Cancer Res"},{"issue":"50","key":"7831_CR28","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1038\/onc.2008.307","volume":"27","author":"K Yip","year":"2008","unstructured":"Yip K, Reed J. Bcl-2 family proteins and cancer. Oncogene. 2008;27(50):6398\u2013406.","journal-title":"Oncogene"},{"key":"7831_CR29","doi-asserted-by":"crossref","unstructured":"Ruan Q, et al. MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2. Cell Death Dis. 2014;5(2):e 1095.","DOI":"10.1038\/cddis.2014.47"},{"issue":"10","key":"7831_CR30","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1007\/s11064-022-03671-4","volume":"47","author":"X Sun","year":"2022","unstructured":"Sun X, et al. Exogenous TIPE2 inhibit TAK1 to improve inflammation and neuropathic pain induced by sciatic nerve Injury through inactivating NF-\u03baB and JNK. Neurochem Res. 2022;47(10):3167\u201377.","journal-title":"Neurochem Res"},{"issue":"2","key":"7831_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1158\/2159-8290.CD-15-0583","volume":"6","author":"A Morello","year":"2016","unstructured":"Morello A, Sadelain M, Adusumilli PS. Mesothelin-targeted CARs: driving T cells to solid tumors. Cancer Discov. 2016;6(2):133\u201346.","journal-title":"Cancer Discov"},{"key":"7831_CR32","doi-asserted-by":"publisher","first-page":"102016","DOI":"10.1016\/j.ctrv.2020.102016","volume":"86","author":"D Schizas","year":"2020","unstructured":"Schizas D, et al. Immunotherapy for pancreatic cancer: a 2020 update. Cancer Treat Rev. 2020;86:102016.","journal-title":"Cancer Treat Rev"},{"key":"7831_CR33","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.3389\/fimmu.2018.02166","volume":"9","author":"M Akce","year":"2018","unstructured":"Akce M, et al. The potential of CAR T cell therapy in pancreatic cancer. Front Immunol. 2018;9:2166.","journal-title":"Front Immunol"},{"key":"7831_CR34","doi-asserted-by":"publisher","first-page":"680985","DOI":"10.3389\/fonc.2021.680985","volume":"11","author":"F Feng","year":"2021","unstructured":"Feng F, et al. TIPE2 suppresses malignancy of pancreatic cancer through inhibiting TGF\u03b21 mediated signaling pathway. Front Oncol. 2021;11:680985.","journal-title":"Front Oncol"},{"key":"7831_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.25259\/Cytojournal_105_2024","volume":"21","author":"J Li","year":"2024","unstructured":"Li J, et al. Methyltransferase-like 14 promotes the tumorigenesis and proliferation of pancreatic cancer cells through myc proto-oncogene signaling pathway. Cytojournal. 2024;21:55.","journal-title":"Cytojournal"},{"issue":"11","key":"7831_CR36","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1080\/14740338.2024.2396387","volume":"24","author":"R Li","year":"2025","unstructured":"Li R, et al. Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis. Expert Opin Drug Saf. 2025;24(11):1253\u201357.","journal-title":"Expert Opin Drug Saf"},{"key":"7831_CR37","unstructured":"Janeway CA Jr, et al. T cell-mediated cytotoxicity. In: Immunobiology: the immune system in health and disease. 5th. Garland Science; 2001."},{"issue":"5","key":"7831_CR38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1158\/2326-6066.CIR-15-0048","volume":"3","author":"AJ Davenport","year":"2015","unstructured":"Davenport AJ, et al. CAR-T cells inflict sequential killing of multiple tumor target cells. Cancer Immunol Res. 2015;3(5):483\u201394.","journal-title":"Cancer Immunol Res"},{"key":"7831_CR39","doi-asserted-by":"crossref","unstructured":"Shi B, et al. The enigmatic role of TIPE2 in asthma. Am J Physiol Lung Cell Mol Physiol. 2020;319(1):L163\u2013l172.","DOI":"10.1152\/ajplung.00069.2020"},{"key":"7831_CR40","doi-asserted-by":"publisher","first-page":"158093","DOI":"10.1016\/j.cej.2024.158093","volume":"503","author":"L Li","year":"2025","unstructured":"Li L, et al. Nanozyme-enhanced tyramine signal amplification probe for preamplification-free myocarditis-related miRNAs detection. Chem Eng J. 2025;503:158093.","journal-title":"Chem Eng J"},{"key":"7831_CR41","doi-asserted-by":"crossref","unstructured":"Buggert M, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10(7):e1004251.","DOI":"10.1371\/journal.ppat.1004251"},{"issue":"1","key":"7831_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00011-025-02031-6","volume":"74","author":"L Rabiu","year":"2025","unstructured":"Rabiu L, et al. TIPE2 deficiency amplifies inflammation and immune dysregulation in MASH through modulating hepatic lipid metabolism and immune cell function. Inflamm Res. 2025;74(1):65.","journal-title":"Inflamm Res"},{"key":"7831_CR43","doi-asserted-by":"crossref","unstructured":"Xu S, et al. TIPE2 acts as a tumor suppressor and correlates with tumor microenvironment immunity in epithelial ovarian cancer. Aging (Albany NY). 2023;15(4):1052\u201373.","DOI":"10.18632\/aging.204529"},{"key":"7831_CR44","doi-asserted-by":"crossref","unstructured":"Huang RY, et al. Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer. Oncoimmunology. 2017;6(1):e1249561.","DOI":"10.1080\/2162402X.2016.1249561"},{"issue":"5","key":"7831_CR45","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","volume":"29","author":"Y Shiravand","year":"2022","unstructured":"Shiravand Y, et al. Immune checkpoint inhibitors in cancer therapy. Curr Oncol. 2022;29(5):3044\u201360.","journal-title":"Curr Oncol"},{"issue":"5","key":"7831_CR46","doi-asserted-by":"publisher","first-page":"755","DOI":"10.4049\/jimmunol.2300433","volume":"212","author":"L Xu","year":"2024","unstructured":"Xu L, Pan F, Guo Z. TIPE2: a Candidate for targeting antitumor immunotherapy. J Immunol. 2024;212(5):755\u201363.","journal-title":"J Immunol"},{"key":"7831_CR47","doi-asserted-by":"publisher","first-page":"7547","DOI":"10.12659\/MSM.917229","volume":"25","author":"H Huang","year":"2019","unstructured":"Huang H, et al. Tumor necrosis factor-\u03b1-induced protein 8-like 2 downregulation reduces CD4+ T lymphocyte apoptosis in mice with thermal Injury. Med Sci Monit. 2019;25:7547\u201356.","journal-title":"Med Sci Monit"},{"key":"7831_CR48","doi-asserted-by":"crossref","unstructured":"Huang W, et al. NFAT and NF-\u03baB dynamically co-regulate TCR and CAR signaling responses in human T cells. Cell Rep. 2023;42(7).","DOI":"10.1016\/j.celrep.2023.112663"},{"key":"7831_CR49","doi-asserted-by":"crossref","unstructured":"Philipson BI, et al. 4-1BB costimulation promotes CAR T cell survival through noncanonical NF-\u03baB signaling. Sci Signaling. 2020;13(625):eaay 8248.","DOI":"10.1126\/scisignal.aay8248"},{"issue":"1","key":"7831_CR50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13062-024-00518-6","volume":"19","author":"Z Liu","year":"2024","unstructured":"Liu Z, et al. Disulfidptosis signature predicts immune microenvironment and prognosis of gastric cancer. Biol Direct. 2024;19(1):65.","journal-title":"Biol Direct"},{"key":"7831_CR51","doi-asserted-by":"publisher","first-page":"110993","DOI":"10.1016\/j.radonc.2025.110993","volume":"209","author":"J Li","year":"2025","unstructured":"Li J, et al. Dynamic joint prediction model of severe radiation-induced oral mucositis among nasopharyngeal carcinoma: a prospective longitudinal study. Radiother Oncol. 2025;209:110993.","journal-title":"Radiother Oncol"},{"key":"7831_CR52","doi-asserted-by":"crossref","unstructured":"Bordoloi D, et al. TIPE family of proteins and its implications in different chronic diseases. Int J Mol Sci. 2018;19(10).","DOI":"10.3390\/ijms19102974"},{"key":"7831_CR53","doi-asserted-by":"publisher","first-page":"110525","DOI":"10.1016\/j.biopha.2020.110525","volume":"130","author":"A Xu","year":"2020","unstructured":"Xu A, et al. NF-\u03baB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity. Biomed Pharmacother. 2020;130:110525.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"7831_CR54","doi-asserted-by":"publisher","first-page":"130706","DOI":"10.1016\/j.bbagen.2024.130706","volume":"1868","author":"A Wu","year":"2024","unstructured":"Wu A, et al. COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma. Biochim Biophys Acta Gen Subj. 2024;1868(11):130706.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"7831_CR55","doi-asserted-by":"crossref","unstructured":"He B, et al. DGHNE: network enhancement-based method in identifying disease-causing genes through a heterogeneous biomedical network. Brief Bioinform. 2022;23(6).","DOI":"10.1093\/bib\/bbac405"},{"key":"7831_CR56","doi-asserted-by":"publisher","first-page":"108198","DOI":"10.1016\/j.compbiomed.2024.108198","volume":"171","author":"H Gong","year":"2024","unstructured":"Gong H, et al. Identification of cuproptosis-related lncRnas with the significance in prognosis and immunotherapy of oral squamous cell carcinoma. Comput Biol Med. 2024;171:108198.","journal-title":"Comput Biol Med"},{"key":"7831_CR57","doi-asserted-by":"crossref","unstructured":"Ren Y, et al. Chimeric cytokine receptor TGF-\u03b2 RII\/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer. Pharmacological Res. 2025;107637.","DOI":"10.1016\/j.phrs.2025.107637"},{"key":"7831_CR58","doi-asserted-by":"crossref","unstructured":"Xiang J, et al. NIDM: network impulsive dynamics on multiplex biological network for disease-gene prediction. Brief Bioinform. 2021;22(5).","DOI":"10.1093\/bib\/bbab080"},{"key":"7831_CR59","doi-asserted-by":"publisher","first-page":"1611948","DOI":"10.3389\/pore.2024.1611948","volume":"30","author":"E Moln\u00e1r","year":"2024","unstructured":"Moln\u00e1r E, et al. Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer. Pathol Oncol Res. 2024;30:1611948.","journal-title":"Pathol Oncol Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07831-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07831-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07831-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:04:00Z","timestamp":1774289040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07831-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7831"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07831-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee of East China Normal University, approval number m20210611.Human peripheral blood mononuclear cells (PBMCs) were kindly provided by the First People\u2019s Hospital of Kunshan, after obtaining approval from the institution under approval number 2023\u201303-061-H02-K00.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declared that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"402"}}